跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAMSIN PROLONGED RELEASE TABLET 0.4MG - HSA Drug Approval Details
Approvals
/
HSA
/
TAMSIN PROLONGED RELEASE TABLET 0.4MG
Approved
THERAPEUTIC
TAMSIN PROLONGED RELEASE TABLET 0.4MG
SYNTHON HISPANIA S.L. - SPAINGE PHARMACEUTICALS, LTD. (PRIMARY & SECONDARY PACKAGER) - BULGARIAROTTENDORF PHARMA GMBH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
May 3, 2018
Approval ID
d8029dc47f5fbea7
Company
SYNTHON HISPANIA S.L. - SPAINGE PHARMACEUTICALS, LTD. (PRIMARY & SECONDARY PACKAGER) - BULGARIAROTTENDORF PHARMA GMBH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
d8029dc47f5fbea7
Drug Name
TAMSIN PROLONGED RELEASE TABLET 0.4MG
Product Name
TAMSIN PROLONGED RELEASE TABLET 0.4MG
Approval Number
SIN15476P
Approval Date
2018-05-03
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
G04CA02
Atc Item Name
tamsulosin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Tamsulosin 0.367mg eqv Tamsulosin Hydrochloride
0.4mg
TAMSULOSIN 0.367 MG EQV TAMSULOSIN HYDROCHLORIDE
0.4 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 3, 2018
Approval ID
d8029dc47f5fbea7
Type
Therapeutic
Back to HSA Approvals